These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 11414763)
1. Mutation analyses of 268 candidate genes in human tumor cell lines. Teng DH; Chen Y; Lian L; Ha PC; Tavtigian SV; Wong AK Genomics; 2001 Jun; 74(3):352-64. PubMed ID: 11414763 [TBL] [Abstract][Full Text] [Related]
2. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Teng DH; Perry WL; Hogan JK; Baumgard M; Bell R; Berry S; Davis T; Frank D; Frye C; Hattier T; Hu R; Jammulapati S; Janecki T; Leavitt A; Mitchell JT; Pero R; Sexton D; Schroeder M; Su PH; Swedlund B; Kyriakis JM; Avruch J; Bartel P; Wong AK; Tavtigian SV Cancer Res; 1997 Oct; 57(19):4177-82. PubMed ID: 9331070 [TBL] [Abstract][Full Text] [Related]
3. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Lerman MI; Minna JD Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536 [TBL] [Abstract][Full Text] [Related]
4. Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene. Su GH; Hilgers W; Shekher MC; Tang DJ; Yeo CJ; Hruban RH; Kern SE Cancer Res; 1998 Jun; 58(11):2339-42. PubMed ID: 9622070 [TBL] [Abstract][Full Text] [Related]
5. BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Wong AK; Shanahan F; Chen Y; Lian L; Ha P; Hendricks K; Ghaffari S; Iliev D; Penn B; Woodland AM; Smith R; Salada G; Carillo A; Laity K; Gupte J; Swedlund B; Tavtigian SV; Teng DH; Lees E Cancer Res; 2000 Nov; 60(21):6171-7. PubMed ID: 11085541 [TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of the coding sequences of MEK-1 and MEK-2 genes in human lung cancer cell lines. Bansal A; Ramirez RD; Minna JD Oncogene; 1997 Mar; 14(10):1231-4. PubMed ID: 9121773 [TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors. Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030 [TBL] [Abstract][Full Text] [Related]
9. The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis. Toomes C; Jackson A; Maguire K; Wood J; Gollin S; Ishwad C; Paterson I; Prime S; Parkinson K; Bell S; Woods G; Markham A; Oliver R; Woodward R; Sloan P; Dixon M; Read A; Thakker N Genes Chromosomes Cancer; 2003 Jun; 37(2):132-40. PubMed ID: 12696061 [TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of four human pancreatic carcinoma cell lines. Genetic alterations in the TGFBR2 gene but not in the MADH4 gene. Ku JL; Yoon KA; Kim WH; Jang Y; Suh KS; Kim SW; Park YH; Park JG Cell Tissue Res; 2002 May; 308(2):205-14. PubMed ID: 12037578 [TBL] [Abstract][Full Text] [Related]
11. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738 [TBL] [Abstract][Full Text] [Related]
12. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers. Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033 [TBL] [Abstract][Full Text] [Related]
14. Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer. Jarrard DF; Bova GS; Ewing CM; Pin SS; Nguyen SH; Baylin SB; Cairns P; Sidransky D; Herman JG; Isaacs WB Genes Chromosomes Cancer; 1997 Jun; 19(2):90-6. PubMed ID: 9171999 [TBL] [Abstract][Full Text] [Related]
15. Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas. Huang L; Goodrow TL; Zhang SY; Klein-Szanto AJ; Chang H; Ruggeri BA Cancer Res; 1996 Mar; 56(5):1137-41. PubMed ID: 8640773 [TBL] [Abstract][Full Text] [Related]
16. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17. Yoshida BA; Dubauskas Z; Chekmareva MA; Christiano TR; Stadler WM; Rinker-Schaeffer CW Cancer Res; 1999 Nov; 59(21):5483-7. PubMed ID: 10554023 [TBL] [Abstract][Full Text] [Related]
17. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer. Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410 [TBL] [Abstract][Full Text] [Related]
18. An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies. Protopopov A; Kashuba V; Zabarovska VI; Muravenko OV; Lerman MI; Klein G; Zabarovsky ER Cancer Res; 2003 Jan; 63(2):404-12. PubMed ID: 12543795 [TBL] [Abstract][Full Text] [Related]
19. Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines. Shapiro GI; Park JE; Edwards CD; Mao L; Merlo A; Sidransky D; Ewen ME; Rollins BJ Cancer Res; 1995 Dec; 55(24):6200-9. PubMed ID: 8521414 [TBL] [Abstract][Full Text] [Related]
20. Mutations of the E-cadherin gene in human gynecologic cancers. Risinger JI; Berchuck A; Kohler MF; Boyd J Nat Genet; 1994 May; 7(1):98-102. PubMed ID: 8075649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]